Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: May 2, 2000
Last updated: June 25, 2013
Last verified: November 2002
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2003
  Estimated Primary Completion Date: No date given